Xtant Medical Holdings (XTNT) Gross Margin (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Gross Margin came in at 66.13% in Q3 2025, up 776.0% year-on-year from 7.55% in Q3 2024, and down 3.57% on a QoQ basis from 68.58% in Q2 2025.
Xtant Medical Holdings (XTNT) Gross Margin (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Gross Margin data on file, last reported at 66.13% in Q3 2025.
- On a quarterly basis, Gross Margin rose 776.0% year-over-year to 66.13% in Q3 2025; TTM through Sep 2025 was 62.02%, a 114.0% increase from a year earlier, with the FY2024 full-year figure at 58.17%, down 258.0% from the prior year.
- Gross Margin for Q3 2025 stood at 66.13%, down from 68.58% in the prior quarter.
- Over the last five years, Gross Margin for XTNT reached as high as 68.58% in Q2 2025 and fell as low as 50.85% in Q4 2024.
- Historically, Gross Margin has averaged 59.43% across 5 years, with a median of 60.97% in 2023.
- Across the five-year window, Gross Margin tumbled 1379 bps in 2021 and surged 776 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 54.69% in 2021, then dropped by 1 bps to 54.39% in 2022, then rose by 12 bps to 60.97% in 2023, then slipped by 17 bps to 50.85% in 2024, then jumped by 30 bps to 66.13% in 2025.
- Per Business Quant data, the three most recent Gross Margin figures were 66.13% in Q3 2025, 68.58% in Q2 2025, and 61.52% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 66.13% |
| Jun 30, 2025 | 68.58% |
| Mar 31, 2025 | 61.52% |
| Dec 31, 2024 | 50.85% |
| Sep 30, 2024 | 58.37% |
| Jun 30, 2024 | 62.06% |
| Mar 31, 2024 | 62.07% |
| Dec 31, 2023 | 60.97% |
| Sep 30, 2023 | 61.29% |
| Jun 30, 2023 | 61.58% |
| Mar 31, 2023 | 58.72% |
| Dec 31, 2022 | 54.39% |
| Sep 30, 2022 | 54.60% |
| Jun 30, 2022 | 54.81% |
| Mar 31, 2022 | 58.38% |
| Dec 31, 2021 | 54.69% |
| Sep 30, 2021 | 52.20% |
| Jun 30, 2021 | 63.54% |
| Mar 31, 2021 | 64.51% |
| Dec 31, 2020 | 64.10% |